Small steps

Small steps

This morning Dexcom announced the FDA approved their SHARE device which enables the Dexcom receiver to wirelessly transmit data to a patient’s smartphone. Now before everyone gets too excited and hails this a major milestone keep in mind the SHARE is basically a docking station and it’s the docking station that is wirelessly transmitting the data. Ultimately the good people at Dexcom hope to convince that FDA to let the receiver, without a docking station, transmit the data. Even better eliminate the need for a receiver altogether and have the sensor itself transmit data to a smartphone.

While not the major innovation many had hoped for this small step is significant and not for reasons many may believe. The fact is Dexcom understands that while everyone in the diabetes world is ready for interconnected diabetes management (IDM), the FDA isn’t quite there yet. Therefore rather than try and convince the FDA to join the rest of us in the 21st Century and realize that most everyone today owns a smartphone and wants this smartphone to become a tool for more effectively managing diabetes. That the FDA needs to be lead down a path, a series of small steps before the diabetes world and Dexcom gets what they want.

This is another reason Diabetic Investor sees Dexcom as one of the premier diabetes device companies. They not only understand what patients want but also understand how the FDA operates and unlike so many others in this space instead of complaining about the FDA they are finding ways to work with the agency. Sure it would be great if the FDA got with the program but honestly this just isn’t going to happen anytime in the near future.

We understand that each step in this process takes time and costs money, this unfortunately is the nature of the beast and if that beast happens to be the FDA small steps are about all we can hope for. Dexcom understands this and is willing to do the heavy lifting today to achieve greater rewards tomorrow. My friends this is the way to manage a diabetes device company for the long term. So congrats to Dexcom and not just for getting the SHARE approved but for showing everyone else in the diabetes device world that’s it’s pretty easy to complain but takes real talent to actually do something.